Ginseng-Containing Sijunzi Decoction Ameliorates Ulcerative Colitis by Orchestrating Gut Homeostasis in Microbial Modulation and Intestinal Barrier Integrity
Authors:
- 1 January 2023
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 51 (03) , 677-699
Abstract
Ulcerative colitis (UC) has become a global epidemic, and the lack of an effective cure highlights the necessity and urgency to explore novel therapies. Sijunzi Decoction (SJZD), a classical Chinese herbal formula, has been comprehensively applied and clinically proven effective in treating UC; however, the pharmacological mechanism behind its therapeutic benefits is largely obscure. Here, we find that SJZD can restore microbiota homeostasis and intestinal barrier integrity in DSS-induced colitis. SJZD significantly alleviated the colonic tissue damage and improved the goblet cell count, MUC2 secretion, and tight junction protein expressions, which indicated enhanced intestinal barrier integrity. SJZD remarkedly suppressed the abundance of phylum Proteobacteria and genus Escherichia-Shigella, which are typical features of microbial dysbiosis. Escherichia-Shigella was negatively correlated with body weight and colon length, and positively correlated with disease activity index and IL-1 . Furthermore, through gut microbiota depletion, we confirmed that SJZD exerted anti-inflammatory activities in a gut microbiota-dependent manner, and fecal microbiota transplantation (FMT) validated the mediating role of gut microbiota in the SJZD treatment of UC. Through gut microbiota, SJZD modulates the biosynthesis of bile acids (BAs), especially tauroursodeoxycholic acid (TUDCA), which has been identified as the signature BA during SJZD treatment. Cumulatively, our findings disclose that SJZD attenuates UC via orchestrating gut homeostasis in microbial modulation and intestinal barrier integrity, thus offering a promising alternative approach to the clinical management of UC.
Keywords
Funding Information
- the Fundamental Research Funds for the Central Universities (2022-JYB-JBZR-009)
- Beijing University of Chinese Medicine High-level Talent Start-up Research Project (2021-XJ-KYQD-004)
- The National Natural Science Foundation of China (82274379)
This publication has 51 references indexed in Scilit:
- Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesisNature Reviews Gastroenterology & Hepatology, 2017
- The evolution of the host microbiome as an ecosystem on a leashNature, 2017
- Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in MiceApplied and Environmental Microbiology, 2017
- Ulcerative colitisThe Lancet, 2017
- Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-κB pathway in Caco2 cellsBMC Complementary and Alternative Medicine, 2017
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Effects of the Sijunzi decoction on the immunological function in rats with dextran sulfate-induced ulcerative colitisBiomedical Reports, 2016
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR AntagonistCell Metabolism, 2013
- A microbial symbiosis factor prevents intestinal inflammatory diseaseNature, 2008
- Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel diseaseInflammatory Bowel Diseases, 2007